Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 385 participants.
Also called NCT02451098
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 385 participants
- Registry
-
NCT02451098
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02451098. Randomized; quadruple masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2015-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Atorvastatin10mg, Ezetimibe10mg
- Intervention (Drug)
- Atorvastatin10mg, Ezetimibe placebo
- Intervention (Drug)
- Atorvastatin20mg, Ezetimibe10mg
- Intervention (Drug)
- Atorvastatin20mg, Ezetimibe placebo
- Intervention (Drug)
- Atorvastatin40mg, Ezetimibe10mg
- Intervention (Drug)
- Atorvastatin40mg, Ezetimibe placebo
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct02451098- Content hash
d1325935be8c5d75e6d1af2e4a810b9bfdb562f3f20eda965a702de73a27c9cc